[Clinical and electrocardiographic considerations on the use of a new synthesis (phenyl-propyl-diphenyl-propyl-amine) in the therapy of syndromes of coronary insufficiency in urologic patients].
D001713:Biphenyl Compounds; D003324:Coronary Artery Disease; D003327:Coronary Disease; D004562:Electrocardiography; D006801:Humans; D011299:Prenylamine; D013577:Syndrome; D014572:Urology
D001713:Biphenyl Compounds; D011299:Prenylamine; C010574:biphenyl
CORONARY DISEASE; SEGONTIN; UROLOGY